Tomasello Shawn
CIK 0001617239
Director
Filings
19
Latest Jan 21, 2026
Issuers covered
5
Showing
19 of 19
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +24.4% | +24.4% | +24.4% | +24.4% |
| 90 days | 1 | 100% | +33.8% | +33.8% | +33.8% | +33.8% |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Tomasello Shawn has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CABA | Cabaletta Bio, Inc. | 5 | Jan 21, 2026 |
| GMDA | Gamida Cell Ltd. | 5 | Feb 2, 2024 |
| FDMT | 4d Molecular Therapeutics, Inc. | 4 | Jun 20, 2025 |
| KLRS | Kalaris Therapeutics, Inc. | 4 | Jun 7, 2024 |
| TCRR | Tcr2 Therapeutics Inc. | 1 | Jun 1, 2023 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|